Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020Research in context

• Main Authors: Yuxuan Wei (Author), Yichen Zhang (Author), Ziyue Xu (Author), Guoan Wang (Author), Yue Zhou (Author), Huangqianyu Li (Author), Luwen Shi (Author), Huseyin Naci (Author), Anita K. Wagner (Author), Xiaodong Guan (Author)
• Format: Book
• Published: Elsevier, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Perceived delays in cancer drug approvals have been a major concern for policymakers in China. Policies have been implemented to accelerate the launch of new cancer drugs and indications. This study aimed to assess similarities and differences between China and the United States...